Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/19/1999 | WO1999041362A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
08/19/1999 | WO1999041359A1 Modified adenovirus containing a fiber replacement protein |
08/19/1999 | WO1999041358A1 A prokaryotic cell comprising two copies of a gene transcribed in different directions |
08/19/1999 | WO1999041355A2 Hiv chemokines |
08/19/1999 | WO1999041284A1 Secreted proteins and polynucleotides encoding them |
08/19/1999 | WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2 |
08/19/1999 | WO1999041271A1 High affinity nucleic acid ligands of complement system proteins |
08/19/1999 | WO1999041258A1 Novel dimerizing agents, their production and use |
08/19/1999 | WO1999041007A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
08/19/1999 | WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives |
08/19/1999 | WO1999040928A1 Novel mixed amylin activity compounds |
08/19/1999 | WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use |
08/19/1999 | WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia |
08/19/1999 | WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells |
08/19/1999 | WO1999036432A3 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
08/19/1999 | WO1999033998A3 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
08/19/1999 | WO1999033985A3 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION |
08/19/1999 | WO1999031255A3 Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
08/19/1999 | WO1999031250A3 Constitutive expression of non-infectious hiv-like particles |
08/19/1999 | WO1999031224A3 Fusion proteins for use in enzymatic synthesis of oligosaccharides |
08/19/1999 | WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd) |
08/19/1999 | WO1999025844A9 Mammalian cell death preventing kinase, dpk |
08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
08/19/1999 | WO1999025380A3 Methods and compositions for the treatment of psoriasis |
08/19/1999 | WO1999024621A3 Methods and compositions for detection of specific nucleotide sequences |
08/19/1999 | WO1999024058A3 Neuronal uses of bmp-11 |
08/19/1999 | WO1999023236A9 Method of dna shuffling |
08/19/1999 | WO1999023227A3 Hyaluronan synthase gene and uses thereof |
08/19/1999 | WO1999023108A9 Inducible phosphofructokinase and the warburg effect |
08/19/1999 | WO1999021415A9 Nuclear transfer for production of transgenic animal embryo |
08/19/1999 | WO1999020753A3 Peptide bond formation using nucleic acid catalysts |
08/19/1999 | WO1999016907A3 Reagent and method for attaching target molecules to a surface |
08/19/1999 | WO1999012945A3 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
08/19/1999 | WO1999005159A3 Staphylococcus specific nucleic acid molecule, test kit and utilization of the nucleic acid molecule and test kit |
08/19/1999 | WO1999004266A3 Interactions of atm, atr or dna-pk with p53 |
08/19/1999 | WO1998055110A3 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION |
08/19/1999 | DE19805788A1 New promoter for the human iodine-transporter gene, used to increase radioactive iodine uptake in tumor cells |
08/19/1999 | DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer |
08/19/1999 | CA2745932A1 Methods for predicting pregnancy outcome in a subject by hcg assay |
08/19/1999 | CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations |
08/19/1999 | CA2521289A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
08/19/1999 | CA2321259A1 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
08/19/1999 | CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes |
08/19/1999 | CA2321135A1 Modified adenovirus containing a fiber replacement protein |
08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
08/19/1999 | CA2321097A1 Anti-viral vectors |
08/19/1999 | CA2321095A1 Nucleotide sequences encoding maize rad51 |
08/19/1999 | CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia |
08/19/1999 | CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines |
08/19/1999 | CA2320958A1 Antigen library immunization |
08/19/1999 | CA2320806A1 Members of the d52 gene family |
08/19/1999 | CA2320784A1 Members of the d52 gene family |
08/19/1999 | CA2320626A1 Genetic vaccine vector engineering |
08/19/1999 | CA2320618A1 Secreted proteins and polynucleotides encoding them |
08/19/1999 | CA2320517A1 Expression vector for the production of dead proteins |
08/19/1999 | CA2320515A1 Therapeutic uses of keratinocyte growth factor-2 |
08/19/1999 | CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors |
08/19/1999 | CA2320431A1 Targeting of genetic vaccine vectors |
08/19/1999 | CA2320427A1 Human receptor proteins |
08/19/1999 | CA2320424A1 Human transport-associated molecules |
08/19/1999 | CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
08/19/1999 | CA2320420A1 Promoter inductible in plants, sequence incorporating same and resulting product |
08/19/1999 | CA2320401A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase |
08/19/1999 | CA2320391A1 Novel cystine knot protein and materials and methods for making it |
08/19/1999 | CA2320389A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
08/19/1999 | CA2320383A1 Hiv chemokines |
08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
08/19/1999 | CA2320031A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
08/19/1999 | CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use |
08/19/1999 | CA2319492A1 Novel dimerizing agents, their production and use |
08/19/1999 | CA2319212A1 Methods for purified aav vector production |
08/19/1999 | CA2319167A1 Interaction between cyclin d1 and steroid receptor co-activators |
08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
08/19/1999 | CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
08/19/1999 | CA2318737A1 Methods for pseudoadenoviral vector production |
08/19/1999 | CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity |
08/19/1999 | CA2312991A1 Prostate-associated serine protease |
08/19/1999 | CA2286747A1 H2-o modified transgenic animals |
08/18/1999 | EP0936271A1 Calcium-activated potassium channel beta subunit gene and protein |
08/18/1999 | EP0936270A2 Serin protease from prostate |
08/18/1999 | EP0935757A1 Assessment of cervical cells |
08/18/1999 | EP0935756A2 Monitoring reactivity of thyroid peroxidase autoantibodies |
08/18/1999 | EP0935678A1 METHODS FOR TREATING BIPOLAR MOOD DISORDER ASSOCIATED WITH MARKERS ON CHROMOSOMES 18p |
08/18/1999 | EP0935677A1 Method for preparing assay supports having an ordered set of reaction zones |
08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
08/18/1999 | EP0935675A1 Nucleic acid primers and probes for detecting oncogenic human papillomaviruses |
08/18/1999 | EP0935674A1 Method for diagnosis of genetic diseases by molecular combing and diagnosis box |
08/18/1999 | EP0935671A1 Methods for preparing arrays of single-stranded dna |
08/18/1999 | EP0935666A1 Methods for altering the rate of plant development and plants obtained therefrom |
08/18/1999 | EP0935665A1 Encapsulation of polypeptides within the starch matrix |
08/18/1999 | EP0935664A2 New systems for regulating genetic expression |
08/18/1999 | EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists |
08/18/1999 | EP0935662A2 Multiple epitope fusion protein |
08/18/1999 | EP0935661A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
08/18/1999 | EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
08/18/1999 | EP0935659A1 Compositions and methods for treating intracellular diseases |
08/18/1999 | EP0935658A1 Genetic control of flowering |
08/18/1999 | EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |